INTERNATIONAL EDITION
INDEPENDENT WORLD NEWS
Politics

WHO members aim for May 2027 agreement on pathogen sharing and health products

Countries ended a two-week round of WHO pandemic-agreement talks on 13 November without a final PABS annex, but committed to continued negotiations before the May 2027 World Health Assembly.

Blue World Health Organization flag flying in front of a Geneva office building.
WHO flag at the organization’s headquarters in Geneva in 2012. Archival contextual photo, not an image from the November 2026 PABS negotiations.
Photo credit and license Photo: World Health Organization Headquarters and Flag (2012) — United States Mission Geneva / Wikimedia Commons, CC BY 2.0. Unmodified archival photograph. · Image source · License: CC BY 2.0 Generic
Text size

Countries negotiating a critical part of the World Health Organization’s pandemic agreement ended their latest round of talks in Geneva on 13 November 2026 with no final text, but with a renewed commitment to reach one by May 2027. The unresolved annex deals with access to pathogens that could cause pandemics and sharing the benefits of research based on them.

The ninth meeting of the Intergovernmental Working Group took place from 2 to 13 November. According to the WHO, negotiators made progress on provisions covering both access to pathogen samples and genetic sequence data, and the fair distribution of resulting medical products. The annex is commonly known as the Pathogen Access and Benefit-Sharing, or PABS, system.

The central challenge is to design a system in which countries and laboratories can exchange biological material and information quickly and transparently, while ensuring more equitable access to vaccines, diagnostic tests and treatments developed with that material. Sharing pathogen data can help scientists respond to emerging threats, but the distribution of subsequent health products is a sensitive political and practical issue.

The World Health Assembly adopted the broader WHO Pandemic Agreement in May 2025. The detailed PABS arrangement was left for further negotiation. The November 2026 statement does not mean that countries have approved the annex or that its rules are already operating. The text still needs agreement and consideration by the World Health Assembly.

The WHO said delegations discussed the roles of laboratories and other technical partners, the practical workings of benefit sharing, and access to samples and sequence information. Participants also acknowledged that complex questions remain. Progress at this stage therefore reflects movement in negotiations, rather than a completed settlement of competing positions.

The working group plans to resume formal sessions on 11–15 January, 15–19 February and 15–25 March 2027, with informal discussions in between. Governments intend to put the proposed annex before the World Health Assembly in May 2027. Meeting that schedule will require compromises on how pathogens and resulting medical tools are shared.

The outcome matters beyond Geneva. If governments agree on workable rules, future outbreaks could be met with faster scientific cooperation and a fairer route to medical countermeasures. If disagreements persist, a central operational element of the pandemic agreement will remain unresolved. For now, the negotiating timetable is clear; the final content of the annex is not.

Source: www.who.int